05:33 PM EDT, 08/19/2025 (MT Newswires) -- Pushkal Garg, Executive Vice President, Chief of R&D, on August 15, 2025, sold 2,851 shares in Alnylam Pharmaceuticals ( ALNY ) for $1,299,746. Following the Form 4 filing with the SEC, Garg has control over a total of 20,902 common shares of the company, with 20,221 shares held directly and 681 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1178670/000173527625000092/xslF345X05/edgardoc.xml